A Phase II Evaluation of Belinostat and Carboplatin in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

BACKGROUND: Patients with recurrent ovarian cancer have limited options, especially in the context of relapse less than six months from primary platinum-based therapy. This Gynecologic Oncology Group (GOG) study was conducted to evaluate the impact of the histone deacetylase inhibitor, belinostat, i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dizon, Don S., Blessing, John A., Penson, Richard T., Drake, Richard D., Walker, Joan L., Johnston, Carolyn M., DiSilvestro, Paul A., Fader, Amanda Nickles
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3330705/
https://ncbi.nlm.nih.gov/pubmed/22366594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2012.02.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados